2120-17-4

Usage

Properties

1. Chemical Name: 2-Allyl-6-bromo-4-methylphenol
2. Common Name: Bromochlorophene
3. Chemical Class: Halogenated phenols
4. Usage: Antiseptic and disinfectant
5. Application: Consumer and industrial products
6. Antimicrobial Properties: Effective against bacteria and fungi
7. Safety: Considered safe at low concentrations but can be irritant and sensitizing
8. Handling: Requires careful handling due to potential skin and eye irritation

Specific Content

1. Chemical Structure: $\textC10\textH11\textBrO$
2. Molecular Weight: 241.10 g/mol
3. Appearance: White to light yellow crystalline solid
4. Odor: Mild phenolic odor
5. Solubility: Soluble in organic solvents like ethanol and acetone
6. Uses: Found in personal care products, medical disinfectants, and sterilization solutions
7. Effectiveness: Broad spectrum antimicrobial activity against various microorganisms
8. Safety Concerns: Potential skin and eye irritant, necessitates careful handling and use in diluted form

Upstream product

• 2120-18-5 2-bromo-4-methyl-1-(2-propen-1-yloxy)benzene 
• 6627-55-0 2-bromo-p-cresol 
• 557-40-4 Allyl ether 
• 106-95-6 allyl bromide 

Relevant academic research and scientific papers

Catalysts for Olefin Polymerization

The present disclosure provides catalyst compounds having a tridentate ethylene bridged amine bis(phenolate) ligand. Catalysts of the present disclosure preferably provide catalyst activity values of 250 gP/mmolCat/hr or greater and polyolefins, such as p

Amine Bridged Anilide Phenolate Catalyst Compounds

The present disclosure provides catalyst compounds having an amine bridged anilide phenolate ligand. In at least one embodiment, catalysts of the present disclosure provide catalyst activity values of about 90 gP/mmolCat·h?1 or greater and poly

PdI2-catalyzed regioselective cyclocarbonylation of 2-allyl phenols to dihydrocoumarins

A simple, efficient, and regioselective synthesis of 3-methyl-3,4-dihydrocoumarins is reported. The reaction of 2-allyl phenols with synthesis gas was catalyzed by PdI2, and 1,3,5,7-tetramethyl-6-phenyl-2,4,8-trioxa-6-phosphaadamantane (L1) and 1,3,5,7-tetramethyl-6-tetradecyl-2,4,8-trioxa-6-phosphaadamantane (L2) were effective as ligands, affording good product selectivity in all cases.

DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AND METHODS FOR USING SAME

Compounds of formula 2 or pharmaceutically acceptable salts thereof are provided: wherein each of R1a, R2a, R3a, Ar, y, and m are as defined herein, which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, are used to treat a variety of central nervous system disorders such as schizophrenia.